Company Description
Valeant Pharmaceuticals is in the anti-virus business, but don't look for its products in the software aisle. The firm makes about 370 prescription...
Key Valeant Financials
| Company Type | Public - NYSE: VRX Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $872.2 |
| 2007 Employees | 3,301 |
More Valeant Financials (11 pages)
Latest Valeant Jobs jobs by Indeed
Rankings
- S&P 400
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Valeant's competition across multiple industries
Top Valeant Competitors
Sponsored Links
The Business Directory
Valeant Executives
| Title | Name & Bio | Contact |
|---|---|---|
| EVP Human Resources and General Counsel | Eileen C. Pruette | Network | E-mail |
| SVP and CFO | Peter J. Blott | Network | E-mail |
| Chairman and CEO | J. Michael (Mike) Pearson | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Valeant News
- BioWorld Today August 29, 2008 [BioWorld Today] (29 Aug 2008 00:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (28 Aug 2008 23:00:00 EDT)
- Briefing.com: Hourly In Play (R) - 22:00 ET [Briefing.com] (28 Aug 2008 22:00:00 EDT)
Sponsored Opportunity
